Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú

Neurology. 1999 Oct 22;53(7):1582-4. doi: 10.1212/wnl.53.7.1582.

Abstract

We describe 11 patients with massive brain infection with viable cysticerci, undetectable inflammatory reaction on CNS imaging, and an unexpectedly high (82%) prevalence of tapeworm infection. With the exception of two individuals with heavy parasite loads, patients had a relatively benign clinical course and tolerated the use of cysticidal drugs. This group of patients represents a particular presentation of neurocysticercosis, different from the previously described syndromes of cysticercotic encephalitis and disseminated systemic cysticercosis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Albendazole / therapeutic use
  • Animals
  • Anthelmintics / therapeutic use
  • Brain Diseases / diagnosis*
  • Brain Diseases / drug therapy
  • Brain Diseases / parasitology*
  • Carrier State*
  • Child
  • Cysticercosis / complications
  • Cysticercosis / epidemiology
  • Cysticercus / isolation & purification
  • Drug Therapy, Combination
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neurocysticercosis / complications
  • Neurocysticercosis / diagnosis*
  • Neurocysticercosis / drug therapy
  • Neurocysticercosis / parasitology*
  • Praziquantel / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anthelmintics
  • Praziquantel
  • Albendazole